|
lymphocyte homeostasis
|
GO_0002260 |
[The process of regulating the proliferation and elimination of lymphocytes such that the total number of lymphocytes within a whole or part of an organism is stable over time in the absence of an outside stimulus.] |
|
vanillin dehydrogenase activity
|
GO_0050608 |
[Catalysis of the reaction: H2O + NAD+ + vanillin = 2 H+ + NADH + vanillate.] |
|
neutrophil homeostasis
|
GO_0001780 |
[The process of regulating the proliferation and elimination of neutrophils such that the total number of neutrophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.] |
|
phosphonate dehydrogenase activity
|
GO_0050609 |
[Catalysis of the reaction: H2O + NAD+ + phosphonate = 2 H+ + NADH + phosphate.] |
|
oxidoreductase activity, acting on phosphorus or arsenic in donors, with NAD(P)+ as acceptor
|
GO_0050499 |
[Catalysis of an oxidation-reduction (redox) reaction in which a phosphorus- or arsenic-containing group acts as a hydrogen or electron donor and reduces a NAD(P)+ to NAD(P)H.] |
|
taxadiene 5-alpha-hydroxylase activity
|
GO_0050604 |
[Catalysis of the reaction: AH2 + O2 + taxa-4,11-diene = A + H2O + taxa-4(20),11-dien-5alpha-ol.] |
|
superoxide reductase activity
|
GO_0050605 |
[Catalysis of the reaction: superoxide + reduced rubredoxin + 2 H+ = H2O2 + rubredoxin.] |
|
4-carboxy-2-hydroxymuconate semialdehyde hemiacetal dehydrogenase activity
|
GO_0050606 |
[Catalysis of the reaction: 4-carboxy-2-hydroxymuconate semialdehyde hemiacetal + NADP+ = 2-oxo-2H-pyran-4,6-dicarboxylate + H+ + NADPH.] |
|
mycothiol-dependent formaldehyde dehydrogenase activity
|
GO_0050607 |
[Catalysis of the reaction: formaldehyde + mycothiol + NAD+ = S-formylmycothiol + NADH + H+.] |
|
replication fork arrest at mating type locus
|
GO_0011000 |
[A process that impedes the progress of the DNA replication fork at natural replication fork pausing sites within the mating type locus.] |
|
plasma membrane repair
|
GO_0001778 |
[The resealing of a cell plasma membrane after cellular wounding due to, for instance, mechanical stress.] |
|
natural killer cell differentiation
|
GO_0001779 |
[The process in which a relatively unspecialized cell acquires the specialized features of a natural killer cell.] |
|
arsenate reductase (azurin) activity
|
GO_0050611 |
[Catalysis of the reaction: H2O + arsenite + 2 oxidized azurin = 2 H+ + 2 reduced azurin + arsenate.] |
|
oxidoreductase activity, acting on phosphorus or arsenic in donors, with a copper protein as acceptor
|
GO_0052882 |
[Catalysis of an oxidation-reduction (redox) reaction in which a phosphorus- or arsenic-containing group acts as a hydrogen or electron donor and reduces a copper protein.] |
|
T cell homeostatic proliferation
|
GO_0001777 |
[The non-specific expansion of T cell populations within a whole or part of an organism to reach to a total number of T cells which will then remain stable over time in the absence of an external stimulus.] |
|
arsenate reductase (donor) activity
|
GO_0050612 |
[Catalysis of the reaction: A + arsenite + H2O = AH(2) + arsenate + 2 H+.] |
|
oxidoreductase activity, acting on phosphorus or arsenic in donors
|
GO_0030613 |
[Catalysis of an oxidation-reduction (redox) reaction in which a phosphorus- or arsenic-containing group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.] |
|
microglial cell activation
|
GO_0001774 |
[The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.] |
|
leukocyte activation involved in inflammatory response
|
GO_0002269 |
[A change in the morphology or behavior of a leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an inflammatory response.] |
|
macrophage activation
|
GO_0042116 |
[A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.] |